Literature DB >> 24443351

Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.

Jarrod E Church1, Jennifer Trieu, Annabel Chee, Timur Naim, Stefan M Gehrig, Séverine Lamon, Corrado Angelini, Aaron P Russell, Gordon S Lynch.   

Abstract

New Findings What is the central question of this study? The Notch signalling pathway plays an important role in muscle regeneration, and activation of the pathway has been shown to enhance muscle regeneration in aged mice. It is unknown whether Notch activation will have a similarly beneficial effect on muscle regeneration in the context of Duchenne muscular dystrophy (DMD). What is the main finding and its importance? Although expression of Notch signalling components is altered in both mouse models of DMD and in human DMD patients, activation of the Notch signalling pathway does not confer any functional benefit on muscles from dystrophic mice, suggesting that other signalling pathways may be more fruitful targets for manipulation in treating DMD. Abstract In Duchenne muscular dystrophy (DMD), muscle damage and impaired regeneration lead to progressive muscle wasting, weakness and premature death. The Notch signalling pathway represents a central regulator of gene expression and is critical for cellular proliferation, differentiation and apoptotic signalling during all stages of embryonic muscle development. Notch activation improves muscle regeneration in aged mice, but its potential to restore regeneration and function in muscular dystrophy is unknown. We performed a comprehensive examination of several genes involved in Notch signalling in muscles from dystrophin-deficient mdx and dko (utrophin- and dystrophin-null) mice and DMD patients. A reduction of Notch1 and Hes1 mRNA in tibialis anterior muscles of dko mice and quadriceps muscles of DMD patients and a reduction of Hes1 mRNA in the diaphragm of the mdx mice were observed, with other targets being inconsistent across species. Activation and inhibition of Notch signalling, followed by measures of muscle regeneration and function, were performed in the mouse models of DMD. Notch activation had no effect on functional regeneration in C57BL/10, mdx or dko mice. Notch inhibition significantly depressed the frequency-force relationship in regenerating muscles of C57BL/10 and mdx mice after injury, indicating reduced force at each stimulation frequency, but enhanced the frequency-force relationship in muscles from dko mice. We conclude that while Notch inhibition produces slight functional defects in dystrophic muscle, Notch activation does not significantly improve muscle regeneration in murine models of muscular dystrophy. Furthermore, the inconsistent expression of Notch targets between murine models and DMD patients suggests caution when making interspecies comparisons.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24443351     DOI: 10.1113/expphysiol.2013.077255

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  14 in total

Review 1.  Notch signaling in oral pre-cancer and oral cancer.

Authors:  Kumud Nigam; Ratnesh Kumar Srivastav
Journal:  Med Oncol       Date:  2021-10-11       Impact factor: 3.064

2.  Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic program.

Authors:  Alexander Morrison-Nozik; Priti Anand; Han Zhu; Qiming Duan; Mohamad Sabeh; Domenick A Prosdocimo; Madeleine E Lemieux; Nikolai Nordsborg; Aaron P Russell; Calum A MacRae; Anthony N Gerber; Mukesh K Jain; Saptarsi M Haldar
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

3.  Methylmercury exposure causes a persistent inhibition of myogenin expression and C2C12 myoblast differentiation.

Authors:  Lisa M Prince; Matthew D Rand
Journal:  Toxicology       Date:  2017-11-15       Impact factor: 4.221

4.  Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.

Authors:  Natassia M Vieira; Ingegerd Elvers; Matthew S Alexander; Yuri B Moreira; Alal Eran; Juliana P Gomes; Jamie L Marshall; Elinor K Karlsson; Sergio Verjovski-Almeida; Kerstin Lindblad-Toh; Louis M Kunkel; Mayana Zatz
Journal:  Cell       Date:  2015-11-12       Impact factor: 41.582

5.  Biochemical and Functional Comparisons of mdx and Sgcg(-/-) Muscular Dystrophy Mouse Models.

Authors:  Nathan W Roberts; Jenan Holley-Cuthrell; Magdalis Gonzalez-Vega; Aaron J Mull; Ahlke Heydemann
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

6.  Notch signaling deficiency underlies age-dependent depletion of satellite cells in muscular dystrophy.

Authors:  Chunhui Jiang; Yefei Wen; Kazuki Kuroda; Kevin Hannon; Michael A Rudnicki; Shihuan Kuang
Journal:  Dis Model Mech       Date:  2014-06-06       Impact factor: 5.758

7.  Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.

Authors:  Kelly M Gutpell; William T Hrinivich; Lisa M Hoffman
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

Review 8.  The quasi-parallel lives of satellite cells and atrophying muscle.

Authors:  Stefano Biressi; Suchitra D Gopinath
Journal:  Front Aging Neurosci       Date:  2015-07-22       Impact factor: 5.750

9.  Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle.

Authors:  Ryan D Welch; Cyrielle Billon; Aurore-Cecile Valfort; Thomas P Burris; Colin A Flaveny
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.996

10.  Interleukin-1beta (IL-1β)-induced Notch ligand Jagged1 suppresses mitogenic action of IL-1β on human dystrophic myogenic cells.

Authors:  Yuki Nagata; Tohru Kiyono; Kikuo Okamura; Yu-Ichi Goto; Masafumi Matsuo; Madoka Ikemoto-Uezumi; Naohiro Hashimoto
Journal:  PLoS One       Date:  2017-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.